EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs

Ling Zhong iD, Yanran Luo, Wanlin Zhang, Qingbing Zheng iD, Xinyu Zhang, Xiaoping Ye, Qisheng Feng, Yi-Xin Chen iD, Xiao Zhang iD, Miao Xu iD

Journal of Virology · 2026

DOI: 10.1128/jvi.01821-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Ling Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carc…. Hauptthemen laut MEDLINE: Lymphocryptovirus, Leukocytes, Mononuclear, Herpesviridae Infections. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) infects more than 90% of adults worldwide and causes a range of diseases, including multiple malignancies and autoimmune disorders. However, due to a host range restriction, EBV cannot infect commonly used experimental animals, posing a significant obstacle to developing EBV-specific prophylactic and therapeutic agents. Rhesus lymphocryptovirus (rhLCV), an ortholog of EBV, naturally infects rhesus macaques, which is a surrogate model for EBV research. In this study, we demonstrate that cynomolgus macaque (Macaca fascicularis), a primate closely related to rhesus macaque, is susceptible to rhLCV infection. rhLCV can immortalize B cells of cynomolgus macaques to develop cy-LCLs. We developed a high rhLCV-producing cy-LCL cell line, LCL111, and optimized the induction conditions to increase viral production, surpassing the original rhLCV producer LCL8664. Importantly, EBV gHgL-specific monoclonal antibody (mAb) AMMO1 and gB-specific mAb 3A5 can cross-react with rhLCV proteins and block the formation of cy-LCLs. Overall, we established an efficient rhLCV-producing cell line, and rhLCV infection of cynomolgus macaques represents a promising alternative surrogate model for efficiency evaluation of EBV vaccines and mAbs. IMPORTANCE Epstein-Barr virus (EBV) naturally infects only humans, creating a major barrier to evaluating the efficiency of vaccines and therapies in vivo . As an EBV ortholog, rhesus lymphocryptovirus (rhLCV) offers a biologically relevant surrogate system. However, its application has been primarily limited to rhesus macaques. Here, we demonstrate that cynomolgus macaque lymphocytes are also susceptible to rhLCV in vitro, and the newly transformed cy-LCL111 shows superior and sustained rhLCV production ability. rhLCV infection of cynomolgus macaque lymphocytes can be efficiently neutralized by anti-EBV gH/gL nAbs AMMO1 and anti-EBV gB mAbs 3A5, highlighting the potential of cynomolgus macaques as an in vivo model to assess anti-EBV mAb and vaccine efficacy. Our findings support the use of cynomolgus macaques as an additional model for EBV research and offer a useful platform for evaluating EBV-specific prophylactic or therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphocryptovirusLeukocytes, MononuclearHerpesviridae InfectionsAnimalsMacaca fascicularisCell LineAntibodies, MonoclonalAntibodies, ViralMacaca mulattaB-LymphocytesHumansVirus ReplicationHerpesvirus 4, Human

Stichwörter der Autor:innen

EBVMacaca fasciculariscross-neutralizationlymphoblastoid cell linerhLCV production

Substanzen

Antibodies, MonoclonalAntibodies, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Gua…
  • State Key Laboratory of Vaccines for Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for I…
  • College of Pharmacy, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Ling Zhong, Qingbing Zheng, Yi-Xin Chen, Xiao Zhang, Miao Xu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Natural Science Foundation of Chongqing City
  • Natural Science Foundation of Beijing City
  • Chongqing Education Commission of Science and Technology Research Project

Zitieren

APA

Zhong, L., Luo, Y., Zhang, W., Zheng, Q., Zhang, X., Ye, X., Feng, Q., Chen, Y. X., Zhang, X., & Xu, M. (2026). Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs. Journal of Virology. https://doi.org/10.1128/jvi.01821-25

Vancouver

Zhong L, Luo Y, Zhang W, Zheng Q, Zhang X, Ye X, et al. Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs. Journal of Virology. 2026. doi:10.1128/jvi.01821-25

BibTeX
@article{Zhong2026,
  author = {Zhong, Ling and Luo, Yanran and Zhang, Wanlin and Zheng, Qingbing and Zhang, Xinyu and Ye, Xiaoping and Feng, Qisheng and Chen, Yi-Xin and Zhang, Xiao and Xu, Miao},
  title = {Enhanced rhLCV production in lymphoblastoid cell lines derived from rhLCV-infected cynomolgus macaque PBMCs},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01821-25}
}
Kostenlos starten →